Expert Perspectives on CDK4/6 Inhibitors in Hormone Receptor–Positive, HER2-Negative Breast Cancer

Get up to date on the latest clinical developments in CDK4/6 inhibitors for the treatment of hormone receptor–positive, HER2-negative MBC with a downloadable slideset from CCO’s live meeting series, and then get treatment guidance customized to your most challenging cases with CCO’s Interactive Decision Support Tool featuring recommendations from a panel of breast cancer experts.
Matthew P. Goetz, MD
Sara Hurvitz, MD, FACP
Mohammad Jahanzeb, MD, FACP
Kathy D. Miller, MD
Ruth O'Regan, MD
Tiffany A. Traina, MD


Read my take on how I choose a specific CDK4/6 inhibitor for patients with MBC based on differential safety profiles and specific presentation characteristics.

Matthew P. Goetz, MD Released: March 29, 2019

Downloadable Slideset

Download this slideset from our 2018 CDK4/6 Inhibitors in HR+/HER2- Breast Cancer Local Live meeting series and review the latest evidence on optimal use of CDK4/6 inhibitors in the management of metastatic breast cancer, expert guidance on managing toxicities with CDK4/6 inhibitors, and insight on future research directions.

Mohammad Jahanzeb, MD, FACP Ruth O'Regan, MD Released: August 28, 2018

Interactive Decision Support Tool

Use this Interactive Decision Support Tool to compare your choice of therapy for patients with MBC with those of 5 breast cancer experts.

Sara Hurvitz, MD, FACP Mohammad Jahanzeb, MD, FACP Kathy D. Miller, MD Ruth O'Regan, MD Tiffany A. Traina, MD Released: September 20, 2018
Jointly provided by Postgraduate Institute for Medicine and Clinical Care Options, LLC
PIM Logo

Postgraduate Institute for Medicine
304 Inverness Way South, Suite 100
Englewood, CO 80112

Allison Hughes, CCMEP, Program Manager
(303) 799-1930
(303) 858-8842 (Fax)

This activity is supported by an educational grant from

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.


Welcome to the CCO site.

You are accessing CCO's educational content today as a Guest user.

If you would like to continue with free, full access to the CCO Web sites, including free CME/CE credits, please click the button below.


More info

CCO’s educational programs are available completely free of charge on the,, and Web sites. Certain features and functions are restricted for Guest users. By consenting to become a full member, you are eligible to receive CME/CE credit or participation certificates from certified activities, to register for CCO’s free live meetings and webinars, and to receive CCO’s email newsletters alerting you to new content. You can unsubscribe from our emails at any time. CCO strictly protects the privacy of our members, according to our privacy policy.

A confirmation email will be sent to . Not You?